Movers & Shakers: New CEOs at Ashley Addiction Treatment, New Directions

Ashley Addiction Treatment appoints joint CEOs 

Ashley Addiction Treatment has promoted two of its senior executives to lead the company. 

Alex Denstman — Ashley’s senior vice president and chief growth officer — and Greg Hobelmann — senior vice president and chief medical and clinical officer — will take over as joint CEOs on March 1.

They will replace Dave Nassef, who has been Ashley’s interim CEO since 2019, when Rebecca Flood vacated the position. When Denstman and Hobelmann take over, Nassef will transition to the role of senior advisor and envoy for Ashley. 


Based in Havre de Grace, Maryland, Ashley is a not-for-profit provider of substance use disorder (SUD) treatment. It has an inpatient facility and two outpatient locations, across which it offers the full continuum of care.

The joint CEO model isn’t new to Ashley. It was founded on a co-leadership structure 38 years ago. The hope is that Denstman and Hobelmann can combine their skill sets to “lead Ashley into the future and ensure its longevity as one of the nation’s leading nonprofit organizations,” according to a press release announcing the news.

New Directions hires new CEO

Following a nationwide search, New Directions Behavioral Health has hired a new president and CEO.


Shana Hoffman, a Beacon Health Options alum, has been named as the new leader of the Kansas City, Missouri-based managed behavioral health care organization. 

New Directions provides managed behavioral health services, an employee assistance program (EAP), a student assistance program, organizational consulting and health coaching to a number of employers and labor groups. It has more than doubled its membership in the past five years and currently has more than 16 million members. 

Before joining New Directions, Hoffman served as senior vice president of corporate transformation and the COO of the tri-state mid-atlantic region for Beacon Health Options.

Hoffman succeeds Lee Tuveson, who left New Directions in early 2020.

Former Deloitte chairman joins Acadia’s board of directors

Acadia Healthcare (Nasdaq: ACHC) has added a new member to its board of directors.

Michael J. Fucci, a former chairman of Deloitte U.S., joined as an independent director last month, growing Acadia’s board to nine members.

Headquartered in Franklin, Tennessee, Acadia has 582 facilities across 40 states, the United Kingdom and Puerto Rico. Its locations include inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

In addition to his role as executive chairman of Deloitte U.S., Fucci also previously served as COO of Deloitte Consulting, where he held various management positions since 2003. In the past, he also served as a member on the boards of directors for Deloitte U.S. and Deloitte global. 

“[Fucci] brings a unique perspective on human resource transformation, corporate talent strategies and risk mitigation that will complement the work and expertise of our other directors,” Reeve Waud, chairman of Acadia’s board of directors, said in a press release announcing the news. “We look forward to his valuable contributions as we execute our growth strategy and pursue our primary objective to deliver long-term value for our stockholders.”

Companies featured in this article:

, ,